Error: Could not add to watchlist. X
+ Watchlist

Bradmer Pharmaceuticals Inc

BMR/H:CN
Venture
0.02
CAD
0.00
0.00%
As of 2:52 PM EDT 4/10/2017
Open
0.02
Day Range
0.02 - 0.02
Volume
30,300
Previous Close
0.02
52Wk Range
0.01 - 0.05
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
0.02
Day Range
0.02 - 0.02
Volume
30,300
Previous Close
0.02
52Wk Range
0.01 - 0.05
YTD Return
33.33%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.01
Market Cap (k CAD)
393.195
Shares Outstanding (m)
19.660
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
Profile
Bradmer Pharmaceuticals Inc. is a biotechnology company focused on development and commercialization of cancer therapies. The lead product candidate, Neuradiab, is a therapy against certain brain cancers.
Address
Wildeboer Dellelce Place
365 Bay Street Suite 800
Toronto, ON M5H 2V1
Canada
Phone
1-416-361-6058
  • Alan Mark Ezrin
    Chairman/President/CEO
  • Paul J Van Damme
    Chief Financial Officer
Show More